12 October 2022: Alexa Berk PhD, Elli Brimble MS – RWW: RWD-supported drug filing and regulatory approval

12 October 2022: Conversation with Alexa Berk PhD (Medical Affairs Director, Digital Health and Data Platforms) and Elli Brimble MS (Research Director, Rare DiseaseResearch Director, Rare Disease) at Invitae (formerly Ciitizen) – We discussed a recent drug approval based on RWE from a RWD-driven digital natural history study in rare disease: https://www.prnewswire.com/news-releases/invitaes-real-world-ciitizen-data-utilized-in-praxis-precision-medicines-prax-222-ind-filing-301627677.html